New biochemical methods to determine androgen sensitivity of prostatic cancer: the relative enzymatic index (REI).
D015096:3-Hydroxysteroid Dehydrogenases / Q000378:metabolism; D013741:3-Oxo-5-alpha-Steroid 4-Dehydrogenase / Q000378:metabolism*; D000230:Adenocarcinoma / Q000378:metabolism* / Q000628:therapy; D000469:Alkaline Phosphatase / Q000378:metabolism; D000818:Animals; D007770:L-Lactate Dehydrogenase / Q000378:metabolism; D007931:Leucyl Aminopeptidase / Q000378:metabolism; D008297:Male; D009374:Neoplasms, Experimental; D010088:Oxidoreductases / Q000378:metabolism*; D011471:Prostatic Neoplasms / Q000378:metabolism* / Q000628:therapy; D051381:Rats; D011944:Receptors, Androgen / Q000378:metabolism*; D011987:Receptors, Steroid / Q000378:metabolism*; D013250:Steroid Hydroxylases / Q000378:metabolism
D011944:Receptors, Androgen; D011987:Receptors, Steroid; D010088:Oxidoreductases; D015096:3-Hydroxysteroid Dehydrogenases; D007770:L-Lactate Dehydrogenase; D013250:Steroid Hydroxylases; D013741:3-Oxo-5-alpha-Steroid 4-Dehydrogenase; D000469:Alkaline Phosphatase; D007931:Leucyl Aminopeptidase